Three biomedical research cores led by accomplished and collaborative scientists provide synergistic infrastructure to facilitate research, ranging from basic discovery to validation and clinical translation of novel therapies, with navigators to promote their use.
Core A - Preclinical Models
The Preclinical Models Core will provide easy access to valuable kidney disease animal models, phenotyping, sophisticated genome editing resources, consultation and services to generate iPS cells from patient tissues and education and training relating to preclinical models through a series of workshops.
CORE B – Kidney Therapeutic Design & Development
The Therapeutics Development Core will provide access and expert guidance to high-throughput analytical platforms, structural-based drug design for pathway targeting, biologics design and large-scale production, clinical-grade cellular therapeutics design and production and nanotechnology-based precision therapeutics targeting.
Core C - Clinical & Translational Study Support
The Clinical and Translational Core will efficiently connect investigators with the most appropriate components of the existing clinical research infrastructure, relevant analytic experts, well-matched methodologic talent, unique data and biosample repositories and community-based research study participants and leaders in bioethics and medical humanities.